Translation, Validation, and Psychometric Evaluation of the Diabetes Quality-of-Life Brief Clinical Inventory: The Urdu Version
Overview
Affiliations
Purpose: The study is aimed to examine the psychometric properties of the Urdu version of the Diabetes Quality-of-Life Brief Clinical Inventory.
Methods: We adopted the forward-backward procedure to translate the Diabetes Quality-of-Life Brief Clinical Inventory (DQoL-BCI) into the Urdu language (lingua franca of Pakistan). The intraclass correlation (ICC) confirmed the consistency of retaining the items, and Cronbach's alpha established the test-re-test reliability. The confirmatory factor analysis (principal axis factoring extraction and oblique rotation with Kaiser normalization) validated the DQoL-BCI in Urdu.
Results: A two-time point with an interval of 2 weeks was used, and the Urdu version of DQoL-BCI was piloted accordingly. The 15-item translated version (DQoL-BCI-U) exhibited a satisfactory Cronbach's value of 0.866 (test) at week 1 and 0.850 at week 3 (re-test). Using the one-way random model with single measurements, the ICC for all 15 items exhibited coefficient values of >0.80. The Kaiser-Meyer-Olkin measure of sampling adequacy and Bartlett's Test of Sphericity revealed relationships of the data and suitability of CFA (0.899, <0.05). Seven factors explaining the total variance of 69% were extracted. With acceptable communalities, all 15 items of DQoL-BCI-U were retained.
Conclusion: The study concludes that the translated version of DQoL-BCI-U is a valid instrument in regions, where Urdu is a communal language of communication and can examine quality-of-life issues during the typical patient-provider encounter.
The best internal structure of the Diabetes Quality of Life Measure (DQOL) in Brazilian patients.
Almeida D, Santos-de-Araujo A, Junior J, Cacere M, Pontes-Silva A, Costa C BMC Public Health. 2024; 24(1):580.
PMID: 38395813 PMC: 10885374. DOI: 10.1186/s12889-024-18090-z.
Alsaraireh M, Al-Kalaldeh M, Alnawafleh K, Dwairej D, Almagharbeh W Curr Diabetes Rev. 2024; 21(2):e090224226838.
PMID: 38347770 DOI: 10.2174/0115733998284163240129073837.